Skip to content
2000
image of Dynamic Changes of Extracellular Matrix in Sepsis: A Review

Abstract

During the pathogenesis of sepsis, extracellular matrix (ECM) impairment represents a critical pathological hallmark. The ECM not only plays pivotal roles in maintaining tissue architecture and physiological functions, but also actively participates in cellular signaling transduction and tissue repair mechanisms. Sepsis-induced systemic inflammatory responses and oxidative stress provoke ECM component degradation and structural remodeling, which, in turn, activate multiple intracellular and intercellular signaling cascades. Bioactive fragments derived from ECM degradation can function as signaling ligands that bind to specific cell surface receptors, triggering downstream pathways that regulate critical cellular processes, including survival, proliferation, migration, and inflammatory activation. The sustained activation of these signaling networks exerts profound pathophysiological consequences, potentially leading to vascular endothelial dysfunction, dysregulated immune cell hyperactivation, and coagulation system abnormalities. Furthermore, these signaling pathways mediate essential regulatory functions during the tissue remodeling phase in late-stage sepsis. While this dynamic ECM remodeling may facilitate tissue repair and regeneration, persistent dysregulation could result in maladaptive fibrosis and permanent organ dysfunction. Collectively, the ECM demonstrates multifaceted involvement in sepsis pathophysiology through its regulatory effects on cellular signaling, functional modulation, and tissue remodeling processes. This article systematically synthesizes current knowledge regarding ECM dynamics in sepsis pathogenesis.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmm/10.2174/0115665240407854251202120058
2026-02-20
2026-03-01

  • From This Site

    /content/journals/cmm/10.2174/0115665240407854251202120058
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Xu J.Q. Zhang W.Y. Fu J.J. Viral sepsis: Diagnosis, clinical features, pathogenesis, and clinical considerations. Mil. Med. Res. 2024 11 1 78 10.1186/s40779‑024‑00581‑0 39676169
    [Google Scholar]
  2. Diaconu L. Musat F. Ion D. Balancing precision and practicality: SOFA. Maedica (Buchar.) 2024 19 4 789 795 10.26574/maedica.2024.19.4.789 39974437
    [Google Scholar]
  3. Kolodyazhna A. Wiersinga W.J. van der Poll T. Aiming for precision: Personalized medicine through sepsis subtyping. Burns Trauma 2025 13 tkae073 10.1093/burnst/tkae073 39759543
    [Google Scholar]
  4. Lemańska-Perek A. Adamik B. Fibronectin and its soluble EDA-FN isoform as biomarkers for inflammation and sepsis. Adv. Clin. Exp. Med. 2019 28 11 1561 1567 10.17219/acem/104531 31596557
    [Google Scholar]
  5. Graham D.B. Robertson C.M. Bautista J. Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCγ2 signaling axis in mice. J. Clin. Invest. 2007 117 11 3445 3452 10.1172/JCI32729 17932569
    [Google Scholar]
  6. Wu Y.K. Chung H.W. Chen Y.T. Chen H.C. Chen I.H. Su W.L. Association of LVV-Hemorphin-7 with sepsis and shock: Roles of cathepsin D and G in hemoglobin metabolism in a prospective ICU cohort study. Biomedicines 2024 12 12 2789 10.3390/biomedicines12122789 39767696
    [Google Scholar]
  7. Aghayan A.H. Mirazimi Y. Nasehi L. Atashi A. The toxic effects of neutrophil extracellular traps on mesenchymal stem cells. Mol. Biol. Rep. 2025 52 1 30 10.1007/s11033‑024‑10134‑2 39614028
    [Google Scholar]
  8. Karamanos N.K. Theocharis A.D. Piperigkou Z. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021 288 24 6850 6912 10.1111/febs.15776 33605520
    [Google Scholar]
  9. Prein C. Beier F. ECM signaling in cartilage development and endochondral ossification. Current Topics in Developmental Biology. Elsevier 2019 Vol. 133 25 47
    [Google Scholar]
  10. Yim A. Smith C. Brown A.M. Osteopontin/secreted phosphoprotein‐1 harnesses glial‐, immune‐, and neuronal cell ligand‐receptor interactions to sense and regulate acute and chronic neuroinflammation. Immunol. Rev. 2022 311 1 224 233 10.1111/imr.13081 35451082
    [Google Scholar]
  11. Jin Y.J. Park I. Hong I.K. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α5β1/αvβ3-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell. Signal. 2011 23 1 125 134 10.1016/j.cellsig.2010.08.012 20816750
    [Google Scholar]
  12. Saidak Z. Le Henaff C. Azzi S. Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells. J. Biol. Chem. 2015 290 11 6903 6912 10.1074/jbc.M114.621219 25631051
    [Google Scholar]
  13. Hornigold K. Baker M.J. Machin P.A. The Rac-GEF Tiam1 controls integrin-dependent neutrophil responses. Front. Immunol. 2023 14 1223653 10.3389/fimmu.2023.1223653 38077328
    [Google Scholar]
  14. Kumar V. Soni U.K. Maurya V.K. Singh K. Jha R.K. Integrin beta8 (ITGB8) activates VAV-RAC1 signaling via FAK in the acquisition of endometrial epithelial cell receptivity for blastocyst implantation. Sci. Rep. 2017 7 1 1885 10.1038/s41598‑017‑01764‑7 28507287
    [Google Scholar]
  15. Chen S. Huang Z. Visalakshan R.M. Plasma polymerized bio-interface directs fibronectin adsorption and functionalization to enhance “epithelial barrier structure” formation via FN-ITG β1-FAK-mTOR signaling cascade. Biomater. Res. 2022 26 1 88 10.1186/s40824‑022‑00323‑0 36572920
    [Google Scholar]
  16. Jain M. Dhanesha N. Doddapattar P. Smooth muscle cell–specific fibronectin-EDA mediates phenotypic switching and neointimal hyperplasia. J. Clin. Invest. 2019 130 1 295 314 10.1172/JCI124708 31763999
    [Google Scholar]
  17. Mavlyutov T.A. Myrah J.J. Chauhan A.K. Liu Y. McDowell C.M. Fibronectin extra domain A (FN-EDA) causes glaucomatous trabecular meshwork, retina, and optic nerve damage in mice. Cell Biosci. 2022 12 1 72 10.1186/s13578‑022‑00800‑y 35619185
    [Google Scholar]
  18. Hernandez H. Roberts A.L. McDowell C.M. Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension. Exp. Eye Res. 2020 191 107920 10.1016/j.exer.2020.107920 31923415
    [Google Scholar]
  19. Yuan X. Wu Y. Lin J. Plasma fibronectin can affect the cytokine profile and monocytes/macrophages function in addition to predicting the prognosis of advanced sepsis. FASEB J. 2022 36 3 e22179 10.1096/fj.202100760RRR 35182399
    [Google Scholar]
  20. Speziale P. Pietrocola G. The Multivalent Role of Fibronectin-Binding Proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in Host Infections. Front. Microbiol. 2020 11 2054 10.3389/fmicb.2020.02054 32983039
    [Google Scholar]
  21. Theocharis A.D. Skandalis S.S. Gialeli C. Karamanos N.K. Extracellular matrix structure. Adv. Drug Deliv. Rev. 2016 97 4 27 10.1016/j.addr.2015.11.001 26562801
    [Google Scholar]
  22. Trapani V. Bonaldo P. Corallo D. Role of the ECM in notochord formation, function and disease. J. Cell Sci. 2017 130 19 3203 3211 10.1242/jcs.175950 28883093
    [Google Scholar]
  23. Maiti G. Frikeche J. Lam C.Y.M. Matrix lumican endocytosed by immune cells controls receptor ligand trafficking to promote TLR4 and restrict TLR9 in sepsis. Proc. Natl. Acad. Sci. USA 2021 118 27 e2100999118 10.1073/pnas.2100999118 34215697
    [Google Scholar]
  24. Wang X. Yao C. Yao X. Dynamic photoelectrical regulation of ECM protein and cellular behaviors. Bioact. Mater. 2023 22 168 179 10.1016/j.bioactmat.2022.09.022 36203959
    [Google Scholar]
  25. Derrick C.J. Noël E.S. The ECM as a driver of heart development and repair. Development 2021 148 5 dev191320 10.1242/dev.191320 33674261
    [Google Scholar]
  26. Gardeazabal L. Izeta A. Elastin and collagen fibres in cutaneous wound healing. Exp. Dermatol. 2024 33 3 e15052 10.1111/exd.15052 38483134
    [Google Scholar]
  27. Mouw J.K. Ou G. Weaver V.M. Extracellular matrix assembly: A multiscale deconstruction. Nat. Rev. Mol. Cell Biol. 2014 15 12 771 785 10.1038/nrm3902 25370693
    [Google Scholar]
  28. Fu Y. Zhou Y. Wang K. Li Z. Kong W. Extracellular matrix interactome in modulating vascular homeostasis and remodeling. Circ. Res. 2024 134 7 931 949 10.1161/CIRCRESAHA.123.324055 38547250
    [Google Scholar]
  29. Fawcett J.W. Fyhn M. Jendelova P. Kwok J.C.F. Ruzicka J. Sorg B.A. The extracellular matrix and perineuronal nets in memory. Mol. Psychiatry 2022 27 8 3192 3203 10.1038/s41380‑022‑01634‑3 35760878
    [Google Scholar]
  30. Schultz G.S. Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009 17 2 153 162 10.1111/j.1524‑475X.2009.00466.x 19320882
    [Google Scholar]
  31. Van Doren S.R. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 2015 44-46 224 231 10.1016/j.matbio.2015.01.005 25599938
    [Google Scholar]
  32. McKee T.J. Perlman G. Morris M. Komarova S.V. Extracellular matrix composition of connective tissues: A systematic review and meta-analysis. Sci. Rep. 2019 9 1 10542 10.1038/s41598‑019‑46896‑0 31332239
    [Google Scholar]
  33. Bax D.V. Smalley H.E. Farndale R.W. Best S.M. Cameron R.E. Cellular response to collagen-elastin composite materials. Acta Biomater. 2019 86 158 170 10.1016/j.actbio.2018.12.033 30586647
    [Google Scholar]
  34. Angel P.M. Comte-Walters S. Ball L.E. Mapping extracellular matrix proteins in formalin-fixed, paraffin-embedded tissues by maldi imaging mass spectrometry. J. Proteome Res. 2018 17 1 635 646 10.1021/acs.jproteome.7b00713 29161047
    [Google Scholar]
  35. Sivaraman K. Shanthi C. Matrikines for therapeutic and biomedical applications. Life Sci. 2018 214 22 33 10.1016/j.lfs.2018.10.056 30449450
    [Google Scholar]
  36. Wang Y. Lu S. Xiong J. ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix. J. Pathol. Clin. Res. 2019 5 1 40 52 10.1002/cjp2.115
    [Google Scholar]
  37. de Castro Brás L.E. Frangogiannis N.G. Extracellular matrix-derived peptides in tissue remodeling and fibrosis. Matrix Biol. 2020 91-92 176 187 10.1016/j.matbio.2020.04.006 32438055
    [Google Scholar]
  38. Kao R.T. Hall J. Stern R. Collagen and elastin synthesis in human stroma and breast carcinoma cell lines: Modulation by the extracellular matrix. Connect. Tissue Res. 1986 14 4 245 255 10.3109/03008208609017468 2938880
    [Google Scholar]
  39. Mindt B.C. Fritz J.H. Next stop: Perivasculature! ILC2s hitch a ride on the CCL8 express. Sci. Immunol. 2019 4 36 eaax4583 10.1126/sciimmunol.aax4583 31175178
    [Google Scholar]
  40. Xu H. Zhang B. Chen Y. Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment. Ann. Rheum. Dis. 2023 82 3 416 427 10.1136/ard‑2022‑222764 36109143
    [Google Scholar]
  41. Sohn H.S. Choi J.W. Jhun J. Tolerogenic nanoparticles induce type II collagen–specific regulatory T cells and ameliorate osteoarthritis. Sci. Adv. 2022 8 47 eabo5284 10.1126/sciadv.abo5284 36427299
    [Google Scholar]
  42. Rachedi N.S. Tang Y. Tai Y.Y. Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness. Cell Metab. 2024 36 6 1335 1350.e8 10.1016/j.cmet.2024.04.010 38701775
    [Google Scholar]
  43. Affandi A.J. Carvalheiro T. Ottria A. CXCL4 drives fibrosis by promoting several key cellular and molecular processes. Cell Rep. 2022 38 1 110189 10.1016/j.celrep.2021.110189 34986347
    [Google Scholar]
  44. Maller O. Drain A.P. Barrett A.S. Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression. Nat. Mater. 2021 20 4 548 559 10.1038/s41563‑020‑00849‑5 33257795
    [Google Scholar]
  45. Ucero A.C. Bakiri L. Roediger B. Fra-2–expressing macrophages promote lung fibrosis. J. Clin. Invest. 2019 129 8 3293 3309 10.1172/JCI125366 31135379
    [Google Scholar]
  46. Wang Q. Notay K. Downey G.P. McCulloch C.A. The leucine-rich repeat region of CARMIL1 regulates IL-1-mediated ERK activation, MMP expression, and collagen degradation. Cell Rep. 2020 31 13 107781 10.1016/j.celrep.2020.107781 32610117
    [Google Scholar]
  47. Zhang Q. Dehaini D. Zhang Y. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 2018 13 12 1182 1190 10.1038/s41565‑018‑0254‑4 30177807
    [Google Scholar]
  48. Nakajima A. Seroogy C.M. Sandora M.R. Antigen-specific T cell–mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 2001 107 10 1293 1301 10.1172/JCI12037 11375419
    [Google Scholar]
  49. Dobie R. Wilson-Kanamori J.R. Henderson B.E.P. Single-Cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell Rep. 2019 29 7 1832 1847.e8 10.1016/j.celrep.2019.10.024 31722201
    [Google Scholar]
  50. Adeva-Andany M.M. Adeva-Contreras L. Fernández-Fernández C. González-Lucán M. Funcasta-Calderón R. Elastic tissue disruption is a major pathogenic factor to human vascular disease. Mol. Biol. Rep. 2021 48 5 4865 4878 10.1007/s11033‑021‑06478‑8 34129188
    [Google Scholar]
  51. Dunshee L.C. Sullivan M.O. Kiick K.L. Therapeutic nanocarriers comprising extracellular matrix-inspired peptides and polysaccharides. Expert Opin. Drug Deliv. 2021 18 11 1723 1740 10.1080/17425247.2021.1988925 34696691
    [Google Scholar]
  52. Daamen W.F. Nillesen S.T.M. Wismans R.G. A biomaterial composed of collagen and solubilized elastin enhances angiogenesis and elastic fiber formation without calcification. Tissue Eng. Part A 2008 14 3 349 360 10.1089/tea.2007.0076 18333787
    [Google Scholar]
  53. Wang Y. Song E.C. Resnick M.B. Elastin in the tumor microenvironment. Adv. Exp. Med. Biol. 2020 1272 1 16 10.1007/978‑3‑030‑48457‑6_1 32845499
    [Google Scholar]
  54. Mitzmacher M. Mithieux S. Weiss A. Hee C. Daniels R. Novel recombinant tropoelastin implants restore skin extracellular matrix. J. Drugs Dermatol. 2020 19 12 1166 1172 10.36849/JDD.2020.5375 33346526
    [Google Scholar]
  55. Camasão D.B. González-Pérez M. Palladino S. Alonso M. Rodríguez-Cabello J.C. Mantovani D. Elastin-like recombinamers in collagen-based tubular gels improve cell-mediated remodeling and viscoelastic properties. Biomater. Sci. 2020 8 12 3536 3548 10.1039/D0BM00292E 32478364
    [Google Scholar]
  56. Chow M.J. Turcotte R. Lin C.P. Zhang Y. Arterial extracellular matrix: A mechanobiological study of the contributions and interactions of elastin and collagen. Biophys. J. 2014 106 12 2684 2692 10.1016/j.bpj.2014.05.014 24940786
    [Google Scholar]
  57. Maquart F.X. Bellon G. Pasco S. Monboisse J.C. Matrikines in the regulation of extracellular matrix degradation. Biochimie 2005 87 3-4 353 360 10.1016/j.biochi.2004.10.006 15781322
    [Google Scholar]
  58. Narasaraju T. Neeli I. Criswell S.L. Neutrophil activity and extracellular matrix degradation: Drivers of lung tissue destruction in fatal COVID-19 cases and implications for long COVID. Biomolecules 2024 14 2 236 10.3390/biom14020236 38397474
    [Google Scholar]
  59. Aziz J. Shezali H. Radzi Z. Molecular mechanisms of stress-responsive changes in collagen and elastin networks in skin. Skin Pharmacol. Physiol. 2016 29 4 190 203 10.1159/000447017 27434176
    [Google Scholar]
  60. Suhar R.A. Huang M.S. Navarro R.S. Aviles Rodriguez G. Heilshorn S.C. A library of elastin-like Proteins with tunable matrix ligands for in vitro 3D neural cell culture. Biomacromolecules 2023 24 12 5926 5939 10.1021/acs.biomac.3c00941 37988588
    [Google Scholar]
  61. Sugita S. Matsumoto T. Multiphoton microscopy observations of 3D elastin and collagen fiber microstructure changes during pressurization in aortic media. Biomech. Model. Mechanobiol. 2017 16 3 763 773 10.1007/s10237‑016‑0851‑9 27878400
    [Google Scholar]
  62. Logsdon A.F. Rhea E.M. Reed M. Banks W.A. Erickson M.A. The neurovascular extracellular matrix in health and disease. Exp. Biol. Med. (Maywood) 2021 246 7 835 844 10.1177/1535370220977195 33302738
    [Google Scholar]
  63. Dogné S. Flamion B. Endothelial glycocalyx impairment in disease. Am. J. Pathol. 2020 190 4 768 780 10.1016/j.ajpath.2019.11.016 32035885
    [Google Scholar]
  64. Rangarajan S. Richter J.R. Richter R.P. Heparanase-enhanced shedding of Syndecan-1 and its role in driving disease pathogenesis and progression. J. Histochem. Cytochem. 2020 68 12 823 840 10.1369/0022155420937087 32623935
    [Google Scholar]
  65. Chelazzi C. Villa G. Mancinelli P. De Gaudio A.R. Adembri C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit. Care 2015 19 1 26 10.1186/s13054‑015‑0741‑z 25887223
    [Google Scholar]
  66. Colineau L. Laabei M. Liu G. Interaction of Streptococcus pyogenes with extracellular matrix components resulting in immunomodulation and bacterial eradication. Matrix Biol. Plus 2020 6-7 100020 10.1016/j.mbplus.2020.100020 33543018
    [Google Scholar]
  67. Han W. Lv Y. Sun Y. The anti-inflammatory activity of specific-sized hyaluronic acid oligosaccharides. Carbohydr. Polym. 2022 276 118699 10.1016/j.carbpol.2021.118699 34823813
    [Google Scholar]
  68. Nadir Y. Heparanase and coagulation-new insights. Rambam Maimonides Med. J. 2014 5 4 e0031 10.5041/RMMJ.10165 25386347
    [Google Scholar]
  69. Kim S.D. Lee H.Y. Shim J.W. Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis. Am. J. Respir. Crit. Care Med. 2011 Oct 29 184 2 243 251 10.1164/rccm.201101‑0004OC 21512167 PMC4222420
    [Google Scholar]
  70. Bhan C. Dash S.P. Dipankar P. Kumar P. Chakraborty P. Sarangi P.P. Investigation of extracellular matrix protein expression dynamics using murine models of systemic inflammation. Inflammation 2019 42 6 2020 2031 10.1007/s10753‑019‑01063‑5 31376095
    [Google Scholar]
  71. Jaurila H. Koskela M. Koivukangas V. Gäddnäs F. Salo T. Ala-Kokko T.I. Growth factor expression is enhanced, and extracellular matrix proteins are depressed in healing skin wounds in septic patients compared with healthy controls. Acta Pathol Microbiol Scand Suppl 2022 130 3 155 168 10.1111/apm.13175 34939229
    [Google Scholar]
  72. Flock J.I. Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections. Mol. Med. Today 1999 5 12 532 537 10.1016/S1357‑4310(99)01597‑X 10562719
    [Google Scholar]
  73. Fan Y. Moser J. van Meurs M. Neo-epitope detection identifies extracellular matrix turnover in systemic inflammation and sepsis: An exploratory study. Crit. Care 2024 28 1 120 10.1186/s13054‑024‑04904‑4 38609959
    [Google Scholar]
  74. Albtoush N. Petrey A.C. The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19. Am. J. Physiol. Cell Physiol. 2022 322 6 C1037 C1046 10.1152/ajpcell.00071.2022 35442830
    [Google Scholar]
  75. Zhao T. Su Z. Li Y. Zhang X. You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct. Target. Ther. 2020 5 1 201 10.1038/s41392‑020‑00303‑7 32929074
    [Google Scholar]
  76. Mohamedi Y. Fontanil T. Cal S. Cobo T. Obaya Á.J. ADAMTS-12: Functions and challenges for a complex metalloprotease. Front. Mol. Biosci. 2021 8 686763 10.3389/fmolb.2021.686763 33996918
    [Google Scholar]
  77. Nadir Y Brenner B Heparanase procoagulant activity in cancer progression. Thromb Res 2016 140 S44 s48.(Suppl. 1) 10.1016/S0049‑3848(16)30097‑4 27067977
    [Google Scholar]
  78. Wu Q. Ghosal K. Kana’an N. On-demand imidazolidinyl urea-based tissue-like, self-healable, and antibacterial hydrogels for infectious wound care. Bioact. Mater. 2025 44 116 130 10.1016/j.bioactmat.2024.10.003 39484021
    [Google Scholar]
  79. Lord M.S. Melrose J. Day A.J. Whitelock J.M. The inter-α-trypsin inhibitor family: Versatile molecules in biology and pathology. J. Histochem. Cytochem. 2020 68 12 907 927 10.1369/0022155420940067 32639183
    [Google Scholar]
  80. Kanchanawong P. Calderwood D.A. Organization, dynamics and mechanoregulation of integrin-mediated cell–ECM adhesions. Nat. Rev. Mol. Cell Biol. 2023 24 2 142 161 10.1038/s41580‑022‑00531‑5 36168065
    [Google Scholar]
  81. Adams J.C. Lawler J. The Thrombospondins. Cold Spring Harb. Perspect. Biol. 2011 3 10 a009712 a2 10.1101/cshperspect.a009712 21875984
    [Google Scholar]
  82. Prakash J. Shaked Y. The Interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov. 2024 14 8 1375 1388 10.1158/2159‑8290.CD‑24‑0002 39091205
    [Google Scholar]
  83. Folkman J. Angiogenesis. Annu. Rev. Med. 2006 57 1 1 18 10.1146/annurev.med.57.121304.131306 16409133
    [Google Scholar]
  84. Meizlish M.L. Kimura Y. Pope S.D. Mechanosensing regulates tissue repair program in macrophages. Sci. Adv. 2024 10 11 eadk6906 10.1126/sciadv.adk6906 38478620
    [Google Scholar]
  85. Vyas M. Demehri S. The extracellular matrix and immunity: Breaking the old barrier in cancer. Trends Immunol. 2022 43 6 423 425 10.1016/j.it.2022.04.004 35527181
    [Google Scholar]
  86. Salinas N. Povolotsky T.L. Landau M. Kolodkin-Gal I. Emerging roles of functional bacterial amyloids in gene regulation, toxicity, and immunomodulation. Microbiol. Mol. Biol. Rev. 2020 85 1 e00062 e20 [PMID: 33239434
    [Google Scholar]
  87. Takada Y. Ye X. Simon S. The integrins. Genome Biol. 2007 8 5 215 10.1186/gb‑2007‑8‑5‑215 17543136
    [Google Scholar]
  88. Ma R. Xie X. Zhao L. Wu Y. Wang J. Discoidin domain receptors (DDRs): Potential implications in periodontitis. J. Cell. Physiol. 2022 237 1 189 198 10.1002/jcp.30560 34431091
    [Google Scholar]
  89. Muto J. Yamasaki K. Taylor K.R. Gallo R.L. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol. Immunol. 2009 47 2-3 449 456 10.1016/j.molimm.2009.08.026 19781786
    [Google Scholar]
  90. Choi Y. Chung H. Jung H. Couchman J.R. Oh E.S. Syndecans as cell surface receptors: Unique structure equates with functional diversity. Matrix Biol. 2011 30 2 93 99 10.1016/j.matbio.2010.10.006 21062643
    [Google Scholar]
  91. Gopal S. Syndecans in inflammation at a glance. Front. Immunol. 2020 11 227 10.3389/fimmu.2020.00227 32133006
    [Google Scholar]
  92. Leitinger B. Transmembrane collagen receptors. Annu. Rev. Cell Dev. Biol. 2011 27 1 265 290 10.1146/annurev‑cellbio‑092910‑154013 21568710
    [Google Scholar]
  93. Lerman Y.V. Lim K. Hyun Y.M. Sepsis lethality via exacerbated tissue infiltration and TLR-induced cytokine production by neutrophils is integrin α3β1-dependent. Blood 2014 124 24 3515 3523 10.1182/blood‑2014‑01‑552943 25278585
    [Google Scholar]
  94. Yuki K. Hou L. Role of β2 Integrins in Neutrophils and Sepsis. Infect. Immun. 2020 88 6 e00031 e20 10.1128/IAI.00031‑20 32205406
    [Google Scholar]
  95. Lin R. Li L. A resolving role for neutrophil CD11d in facilitating neutrophil survival and macrophage efferocytosis during sepsis? J. Leukoc. Biol. 2021 109 5 861 863 10.1002/JLB.4CE1220‑794R 33527505
    [Google Scholar]
  96. Koutsogiannaki S. Hou L. Okuno T. Shibamura-Fujiogi M. Luo H.R. Yuki K. αDβ2 as a novel target of experimental polymicrobial sepsis. Front. Immunol. 2022 13 1059996 10.3389/fimmu.2022.1059996 36466931
    [Google Scholar]
  97. Chen K. Murao A. Arif A. Inhibition of efferocytosis by extracellular CIRP–induced neutrophil extracellular traps. J. Immunol. 2021 206 4 797 806 10.4049/jimmunol.2000091 33380498
    [Google Scholar]
  98. Nader D. Curley G.F. Kerrigan S.W. A new perspective in sepsis treatment: Could RGD-dependent integrins be novel targets? Drug Discov. Today 2020 25 12 2317 2325 10.1016/j.drudis.2020.09.038 33035665
    [Google Scholar]
  99. Hakanpaa L. Kiss E.A. Jacquemet G. Targeting β1-integrin inhibits vascular leakage in endotoxemia. Proc. Natl. Acad. Sci. USA 2018 115 28 E6467 E6476 10.1073/pnas.1722317115 29941602
    [Google Scholar]
  100. Wang L. Tang Y. Tang J. Endothelial cell‐derived extracellular vesicles expressing surface VCAM1 promote sepsis‐related acute lung injury by targeting and reprogramming monocytes. J. Extracell. Vesicles 2024 13 3 e12423 10.1002/jev2.12423 38491216
    [Google Scholar]
  101. Sarangi P.P. Hyun Y.M. Lerman Y.V. Pietropaoli A.P. Kim M. Role of β1 integrin in tissue homing of neutrophils during sepsis. Shock 2012 38 3 281 287 10.1097/SHK.0b013e31826136f8 22683734
    [Google Scholar]
  102. Mei S. Tang R. Hu Y. Integrin β3 Mediates Sepsis and mechanical ventilation-associated pulmonary fibrosis through glycometabolic reprogramming. Lab. Invest. 2023 103 1 100021 10.1016/j.labinv.2022.100021 36748196
    [Google Scholar]
  103. Liu Y.S. Chen W.L. Zeng Y.W. Isaridin E protects against sepsis by inhibiting von willebrand factor-induced endothelial hyperpermeability and platelet–endothelium interaction. Mar. Drugs 2024 22 6 283 10.3390/md22060283 38921594
    [Google Scholar]
  104. Dash S.P. Chakraborty P. Sarangi P.P. Inflammatory monocytes and subsets of macrophages with distinct surface phenotype correlate with specific integrin expression profile during murine sepsis. J. Immunol. 2021 207 11 2841 2855 10.4049/jimmunol.2000821 34732468
    [Google Scholar]
  105. Heffernan D.S. Monaghan S.F. Ayala A. Lymphocyte integrin expression differences between SIRS and sepsis patients. Ir. J. Med. Sci. 2017 186 4 981 987 10.1007/s11845‑016‑1525‑4 27796667
    [Google Scholar]
  106. Sun J.K. Zhang Q. Shen X. Integrin αEβ7 is involved in the intestinal barrier injury of sepsis. Aging (Albany NY) 2022 14 2 780 788 10.18632/aging.203839 35042191
    [Google Scholar]
  107. Kawamoto E. Nago N. Okamoto T. Anti-adhesive effects of human soluble thrombomodulin and its domains. Biochem. Biophys. Res. Commun. 2019 511 2 312 317 10.1016/j.bbrc.2019.02.041 30777333
    [Google Scholar]
  108. Okamoto T. Tanigami H. Suzuki K. Shimaoka M. Thrombomodulin: A bifunctional modulator of inflammation and coagulation in sepsis. Crit. Care Res. Pract. 2012 2012 1 10 10.1155/2012/614545 22482044
    [Google Scholar]
  109. Hou L. Yuki K. CD11a regulates hematopoietic stem and progenitor cells. Front. Immunol. 2023 14 1219953 10.3389/fimmu.2023.1219953 37781399
    [Google Scholar]
  110. Duan M. Zhang X. Lou Y. Deletion of Tmem268 in mice suppresses anti-infectious immune responses by downregulating CD11b signaling. EMBO Rep. 2024 25 6 2550 2570 10.1038/s44319‑024‑00141‑6 38730209
    [Google Scholar]
  111. Guo R.F. Riedemann N.C. Laudes I.J. Altered neutrophil trafficking during sepsis. J. Immunol. 2002 169 1 307 314 10.4049/jimmunol.169.1.307 12077259
    [Google Scholar]
  112. Ding X. Tong Y. Jin S. Mechanical ventilation enhances extrapulmonary sepsis-induced lung injury: Role of WISP1–αvβ5 integrin pathway in TLR4-mediated inflammation and injury. Crit. Care 2018 22 1 302 10.1186/s13054‑018‑2237‑0 30445996
    [Google Scholar]
  113. McDonald B. McAvoy E.F. Lam F. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 2008 205 4 915 927 10.1084/jem.20071765 18362172
    [Google Scholar]
  114. Li L.H. Hsu D.Z. Chandrasekaran V.R.M. Liu M.Y. Inhibiting CD44-ICD attenuates LPS-induced initiation of hepatic inflammation in septic mice. Int. J. Mol. Sci. 2024 25 16 8907 10.3390/ijms25168907 39201593
    [Google Scholar]
  115. Rampanelli E. Dessing M.C. Claessen N. CD44-deficiency attenuates the immunologic responses to LPS and delays the onset of endotoxic shock-induced renal inflammation and dysfunction. PLoS One 2013 Dec 23 8 12 e84479 10.1371/journal.pone.0084479 24376813 PMC3871539
    [Google Scholar]
  116. Lee J.H. Liu A. Park J.H. Therapeutic effects of hyaluronic acid in peritonitis-induced sepsis in mice. Shock 2020 54 4 488 497 10.1097/SHK.0000000000001512 31977961
    [Google Scholar]
  117. Singleton P.A. Mirzapoiazova T. Guo Y. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010 299 5 L639 L651 10.1152/ajplung.00405.2009 20709728
    [Google Scholar]
  118. Serbanescu M.A. Ramonell K.M. Hadley A. Attrition of memory CD8 T cells during sepsis requires LFA-1. J. Leukoc. Biol. 2016 100 5 1167 1180 10.1189/jlb.4A1215‑563RR 27286793
    [Google Scholar]
  119. Xie J. Chen C. Sun Y. Increased attrition of memory T cells during sepsis requires 2B4. JCI Insight 2019 4 9 e126030 10.1172/jci.insight.126030 31045575
    [Google Scholar]
  120. Condotta S.A. Rai D. James B.R. Griffith T.S. Badovinac V.P. Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. J. Immunol. 2013 190 5 1991 2000 10.4049/jimmunol.1202379 23355736
    [Google Scholar]
  121. Qin Y. Qian Y. Liu S. Chen R. TOX does not drive sepsis‐induced T‐cell exhaustion. Eur. J. Immunol. 2025 55 2 e202451395 10.1002/eji.202451395 39676393
    [Google Scholar]
  122. Hasan Z. Palani K. Rahman M. Thorlacius H. Targeting CD44 expressed on neutrophils inhibits lung damage in abdominal sepsis. Shock 2011 35 6 567 572 10.1097/SHK.0b013e3182144935 21330943
    [Google Scholar]
  123. Yang X. Meegan J.E. Jannaway M. Coleman D.C. Yuan S.Y. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation. Cardiovasc. Res. 2018 114 13 1752 1763 10.1093/cvr/cvy167 29939250
    [Google Scholar]
  124. Lin C.Y. Kolliopoulos C. Huang C.H. High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity. EBioMedicine 2019 48 425 441 10.1016/j.ebiom.2019.09.014 31526718
    [Google Scholar]
  125. Østerholt H.C.D. Lundeland B. Sonerud T. Saugstad O.D. Nakstad B. The impact of hyaluronan on monocyte Toll‐like receptor expression in term infant cord blood. Acta Paediatr. 2012 101 7 706 713 10.1111/j.1651‑2227.2012.02650.x 22372604
    [Google Scholar]
  126. Ju G.X. Hu Y.B. Du M.R. Jiang J.L. Discoidin domain receptors (DDRs): Potential implications in atherosclerosis. Eur. J. Pharmacol. 2015 751 28 33 10.1016/j.ejphar.2015.01.033 25657115
    [Google Scholar]
  127. Ma Y. Gong H. Cheng L. Zhang D. Discoid domain receptors signaling in macrophages-mediated diseases. Int. J. Gen. Med. 2025 18 907 926 10.2147/IJGM.S487093 39990299
    [Google Scholar]
  128. Li Y. Lu X. Ren X. Ding K. Small molecule discoidin domain receptor kinase inhibitors and potential medical applications. J. Med. Chem. 2015 58 8 3287 3301 10.1021/jm5012319 25569119
    [Google Scholar]
  129. Liu S. Li X. Chen C. Design, synthesis, and biological evaluation of novel discoidin domain receptor inhibitors for the treatment of lung adenocarcinoma and pulmonary fibrosis. Eur. J. Med. Chem. 2024 265 116100 10.1016/j.ejmech.2023.116100 38171149
    [Google Scholar]
  130. Borza C.M. Pozzi A. Discoidin domain receptors in disease. Matrix Biol. 2014 34 185 192 10.1016/j.matbio.2013.12.002 24361528
    [Google Scholar]
  131. Dong Y. Tang B. Wang Q. Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis. Acta Pharmacol. Sin. 2022 43 7 1769 1779 10.1038/s41401‑021‑00808‑z 34819618
    [Google Scholar]
  132. Borza C.M. Bolas G. Pozzi A. Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease. Front. Pharmacol. 2022 13 1001122 10.3389/fphar.2022.1001122 36249782
    [Google Scholar]
  133. Fowler A.J. Hebron M. Balaraman K. Discoidin domain receptor 1 is a therapeutic target for neurodegenerative diseases. Hum. Mol. Genet. 2020 29 17 2882 2898 10.1093/hmg/ddaa177 32776088
    [Google Scholar]
  134. Hebron M. Peyton M. Liu X. Discoidin domain receptor inhibition reduces neuropathology and attenuates inflammation in neurodegeneration models. J. Neuroimmunol. 2017 311 1 9 10.1016/j.jneuroim.2017.07.009 28863860
    [Google Scholar]
  135. Sannomiya Y. Kaseda S. Kamura M. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model. Ren. Fail. 2021 43 1 510 519 10.1080/0886022X.2021.1896548 33706638
    [Google Scholar]
  136. Vella V. Malaguarnera R. Nicolosi M.L. Morrione A. Belfiore A. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection. Biochim. Biophys. Acta Mol. Cell Res. 2019 1866 11 118522 10.1016/j.bbamcr.2019.118522 31394114
    [Google Scholar]
  137. Berdiaki A. Neagu M. Tzanakakis P. Spyridaki I. Pérez S. Nikitovic D. Extracellular matrix components and mechanosensing pathways in health and disease. Biomolecules 2024 14 9 1186 10.3390/biom14091186 39334952
    [Google Scholar]
  138. Thota L.N.R. Chignalia A.Z. The role of the glypican and syndecan families of heparan sulfate proteoglycans in cardiovascular function and disease. Am. J. Physiol. Cell Physiol. 2022 323 4 C1052 C1060 10.1152/ajpcell.00018.2022 35993518
    [Google Scholar]
  139. Couchman J.R. Gopal S. Lim H.C. Nørgaard S. Multhaupt H.A.B. Fell‐Muir Lecture: Syndecans: From peripheral coreceptors to mainstream regulators of cell behaviour. Int. J. Exp. Pathol. 2015 96 1 1 10 10.1111/iep.12112 25546317
    [Google Scholar]
  140. Gopal S. Arokiasamy S. Pataki C. Whiteford J.R. Couchman J.R. Syndecan receptors: Pericellular regulators in development and inflammatory disease. Open Biol. 2021 11 2 200377 10.1098/rsob.200377 33561383
    [Google Scholar]
  141. Ricard-Blum S. Couchman J.R. Conformations, interactions and functions of intrinsically disordered syndecans. Biochem. Soc. Trans. 2023 51 3 1083 1096 10.1042/BST20221085 37334846
    [Google Scholar]
  142. Alexopoulou A.N. Multhaupt H.A.B. Couchman J.R. Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 2007 39 3 505 528 10.1016/j.biocel.2006.10.014 17097330
    [Google Scholar]
  143. Arnold K. Xu Y. Sparkenbaugh E.M. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure. Sci. Transl. Med. 2020 12 535 eaav8075 10.1126/scitranslmed.aav8075 32188725
    [Google Scholar]
  144. Derler R. Gesslbauer B. Weber C. Strutzmann E. Miller I. Kungl A. Glycosaminoglycan-mediated downstream signaling of CXCL8 binding to endothelial cells. Int. J. Mol. Sci. 2017 18 12 2605 10.3390/ijms18122605 29207576
    [Google Scholar]
  145. Zhu Z. Ling X. Zhou H. Xie J. Syndecan-4 is the key proteoglycan involved in mediating sepsis-associated lung injury. Heliyon 2023 9 8 e18600 10.1016/j.heliyon.2023.e18600 37576224
    [Google Scholar]
  146. Theocharis A.D. Gialeli C. Bouris P. Cell–matrix interactions: Focus on proteoglycan–proteinase interplay and pharmacological targeting in cancer. FEBS J. 2014 281 22 5023 5042 10.1111/febs.12927 25333340
    [Google Scholar]
  147. Tsoyi K. Esposito A.J. Sun B. Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts. Sci. Rep. 2022 12 1 2847 10.1038/s41598‑022‑06678‑7 35181688
    [Google Scholar]
  148. Han S. Zhuang H. Shumyak S. A novel subset of anti-inflammatory CD138+ macrophages is deficient in mice with experimental lupus. J. Immunol. 2017 199 4 1261 1274 10.4049/jimmunol.1700099 28696256
    [Google Scholar]
  149. Aquino R.S. Hayashida K. Hayashida A. Park P.W. Role of HSPGs in systemic bacterial infections. Methods Mol. Biol. 2022 2303 605 625 10.1007/978‑1‑0716‑1398‑6_46 34626410
    [Google Scholar]
  150. Stewart M.D. Sanderson R.D. Heparan sulfate in the nucleus and its control of cellular functions. Matrix Biol. 2014 35 56 59 10.1016/j.matbio.2013.10.009 24309018
    [Google Scholar]
  151. Schlömmer C. Brandtner A. Bachler M. Antithrombin and its role in host defense and inflammation. Int. J. Mol. Sci. 2021 22 8 4283 10.3390/ijms22084283 33924175
    [Google Scholar]
  152. Doody K.M. Stanford S.M. Sacchetti C. Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy. Sci. Transl. Med. 2015 7 288 288ra76 10.1126/scitranslmed.aaa4616 25995222
    [Google Scholar]
  153. Koliakou E. Eleni M. Koumentakou I. Altered distribution and expression of syndecan-1 and -4 as an additional hallmark in psoriasis. Int. J. Mol. Sci. 2022 23 12 6511 10.3390/ijms23126511 35742957
    [Google Scholar]
  154. Day R. Forbes A. Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease. Lancet 1999 354 9172 62 65 10.1016/S0140‑6736(98)09267‑8 10406379
    [Google Scholar]
  155. Theocharis A.D. Karamanos N.K. Proteoglycans remodeling in cancer: Underlying molecular mechanisms. Matrix Biol. 2019 75-76 220 259 10.1016/j.matbio.2017.10.008 29128506
    [Google Scholar]
  156. Teixeira F.C.O.B. Götte M. Involvement of Syndecan-1 and Heparanase in cancer and inflammation. Adv. Exp. Med. Biol. 2020 1221 97 135 10.1007/978‑3‑030‑34521‑1_4 32274708
    [Google Scholar]
  157. Ricard-Blum S. Vivès R.R. Schaefer L. A biological guide to glycosaminoglycans: Current perspectives and pending questions. FEBS J. 2024 291 15 3331 3366 10.1111/febs.17107 38500384
    [Google Scholar]
  158. Critchley D.R. Biochemical and structural properties of the integrin-associated cytoskeletal protein talin. Annu. Rev. Biophys. 2009 38 1 235 254 10.1146/annurev.biophys.050708.133744 19416068
    [Google Scholar]
  159. Winograd-Katz S.E. Fässler R. Geiger B. Legate K.R. The integrin adhesome: From genes and proteins to human disease. Nat. Rev. Mol. Cell Biol. 2014 15 4 273 288 10.1038/nrm3769 24651544
    [Google Scholar]
  160. Kruger R.P. Aurandt J. Guan K.L. Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 2005 6 10 789 800 10.1038/nrm1740 16314868
    [Google Scholar]
  161. Canel M. Sławińska A.D. Lonergan D.W. FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. Gut 2024 73 1 131 155 10.1136/gutjnl‑2022‑327927 36977556
    [Google Scholar]
  162. Oguri Y. Shinoda K. Kim H. CD81 controls beige fat progenitor cell growth and energy balance via FAK signaling. Cell 2020 182 3 563 577.e20 10.1016/j.cell.2020.06.021 32615086
    [Google Scholar]
  163. Zhang M. Huang Y. Pan J. An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS -mutant intrahepatic cholangiocarcinoma. Cancer Discov. 2023 13 10 2248 2269 10.1158/2159‑8290.CD‑23‑0282 37486241
    [Google Scholar]
  164. Cheng F. Nussinov R. KRAS activating signaling triggers arteriovenous malformations. Trends Biochem. Sci. 2018 43 7 481 483 10.1016/j.tibs.2018.04.007 29748115
    [Google Scholar]
  165. Kortlever R.M. Sodir N.M. Wilson C.H. Myc cooperates with ras by programming inflammation and immune suppression. Cell 2017 171 6 1301 1315.e14 10.1016/j.cell.2017.11.013 29195074
    [Google Scholar]
  166. Cao L. Zhu S. Lu H. Helicobacter pylori–induced RASAL2 through activation of nuclear factor-κB promotes gastric tumorigenesis via β-catenin signaling axis. Gastroenterology 2022 162 6 1716 1731.e17 10.1053/j.gastro.2022.01.046 35134322
    [Google Scholar]
  167. Menon M.B. Gaestel M. MK2–TNF–signaling comes full circle. Trends Biochem. Sci. 2018 43 3 170 179 10.1016/j.tibs.2017.12.002 29275999
    [Google Scholar]
  168. Ronkina N. Gaestel M. MAPK-activated protein kinases: Servant or partner? Annu. Rev. Biochem. 2022 91 1 505 540 10.1146/annurev‑biochem‑081720‑114505 35303787
    [Google Scholar]
  169. Wilk C.M. Cathomas F. Török O. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders. Immunity 2023 56 12 2790 2802.e6 10.1016/j.immuni.2023.11.011 38091952
    [Google Scholar]
  170. Fu K. Cheung A.H.K. Wong C.C. Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice. Cell 2024 187 4 882 896.e17 10.1016/j.cell.2024.01.004 38295787
    [Google Scholar]
  171. Datta J. Dai X. Bianchi A. Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer. Gastroenterology 2022 163 6 1593 1612 10.1053/j.gastro.2022.07.076 35948109
    [Google Scholar]
  172. Wu Y. Wang Q. Li M. SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis. J. Clin. Invest. 2023 133 6 e150224 10.1172/JCI150224 36749634
    [Google Scholar]
  173. Arthur J.S.C. Ley S.C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 2013 13 9 679 692 10.1038/nri3495 23954936
    [Google Scholar]
  174. Wang L. Zhang X. Lin Z.B. Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1. Cell Metab. 2021 33 7 1372 1388.e7 10.1016/j.cmet.2021.05.019 34146477
    [Google Scholar]
  175. Georgilis A. Gil J. Controlling secretion to limit chemoresistance. Genes Dev. 2016 30 16 1791 1792 10.1101/gad.288571.116 27601527
    [Google Scholar]
  176. Wang Y. Fu Z. Li X. Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation. Immunity 2021 54 4 632 647.e9 10.1016/j.immuni.2021.02.003 33667382
    [Google Scholar]
  177. Fu Y.J. Zhao X. Wang L.Y. A gas therapy strategy for intestinal flora regulation and colitis treatment by nanogel‐based multistage no delivery microcapsules. Adv. Mater. 2024 36 19 2309972 10.1002/adma.202309972 38324725
    [Google Scholar]
  178. Kim S.M. Park S. Hwang S.H. Secreted akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis. Cell Host Microbe 2023 31 6 1021 1037.e10 10.1016/j.chom.2023.05.007 37269833
    [Google Scholar]
  179. Chen H.R. Sun Y. Mittler G. MOF-mediated PRDX1 acetylation regulates inflammatory macrophage activation. Cell Rep. 2024 43 9 114682 10.1016/j.celrep.2024.114682 39207899
    [Google Scholar]
  180. Chen M. Li Y. Zhu J.Y. Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling. Cell Rep. 2025 44 2 115251 10.1016/j.celrep.2025.115251 39891907
    [Google Scholar]
  181. Zou X. Wang K. Deng Y. Hypoxia-inducible factor 2α promotes pathogenic polarization of stem-like Th2 cells via modulation of phospholipid metabolism. Immunity 2024 57 12 2808 2826.e8 10.1016/j.immuni.2024.11.001 39609127
    [Google Scholar]
  182. Kim D. Kim G. Yu R. Inhibitory co-receptor Lag3 supports Foxp3+ regulatory T cell function by restraining Myc-dependent metabolic programming. Immunity 2024 57 11 2634 2650.e5 10.1016/j.immuni.2024.08.008 39236718
    [Google Scholar]
  183. Barber D.F. Bartolomé A. Hernandez C. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat. Med. 2005 11 9 933 935 10.1038/nm1291 16127435
    [Google Scholar]
  184. Stern R.M. Berliner N. Targeting the mTOR pathway in idiopathic multicentric castleman disease. J. Clin. Invest. 2019 129 10 4086 4088 10.1172/JCI131332 31524635
    [Google Scholar]
  185. Terashima Y. Onai N. Murai M. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat. Immunol. 2005 6 8 827 835 10.1038/ni1222 15995708
    [Google Scholar]
  186. Jiang X. Ma J. Xue K. Highly bioactive MXene-M2-exosome nanocomposites promote angiogenic diabetic wound repair through reconstructing high glucose-derived immune inhibition. ACS Nano 2024 18 5 4269 4286 10.1021/acsnano.3c09721 38270104
    [Google Scholar]
  187. Malik M.N.H. Waqas S.F.H. Zeitvogel J. Congenital deficiency reveals critical role of ISG15 in skin homeostasis. J. Clin. Invest. 2022 132 3 e141573 10.1172/JCI141573 34847081
    [Google Scholar]
  188. Albrengues J. Shields M.A. Ng D. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 2018 361 6409 eaao4227 10.1126/science.aao4227 30262472
    [Google Scholar]
  189. Kheradmand F. Werner E. Tremble P. Symons M. Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998 280 5365 898 902 10.1126/science.280.5365.898 9572733
    [Google Scholar]
  190. Ding L. Lu Z. Foreman O. Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology 2012 142 2 305 315 10.1053/j.gastro.2011.10.025 22044670
    [Google Scholar]
  191. Morris D.G. Huang X. Kaminski N. Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 2003 422 6928 169 173 10.1038/nature01413 12634787
    [Google Scholar]
  192. Shimizu K. Shichiri M. Libby P. Lee R.T. Mitchell R.N. Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas. J. Clin. Invest. 2004 114 2 300 308 10.1172/JCI200419855 15254597
    [Google Scholar]
  193. Kopec A.K. Joshi N. Cline-Fedewa H. Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12. J. Hepatol. 2017 66 4 787 797 10.1016/j.jhep.2016.12.004 27965156
    [Google Scholar]
  194. Lin X. Chen W. Yang G. Viral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli. J. Clin. Invest. 2024 134 19 e176828 10.1172/JCI176828 39352385
    [Google Scholar]
  195. Liu M. Yan M. Lv H. Macrophage K63-Linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis. Cell Rep. 2020 32 5 107990 10.1016/j.celrep.2020.107990 32755583
    [Google Scholar]
  196. Zhang Y.S. Xin D.E. Wang Z. STAT 4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation. EMBO J. 2019 38 6 1 20 10.15252/embj.201899595 30770344
    [Google Scholar]
  197. Zhou X. Li W. Wang S. YAP Aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis. Cell Rep. 2019 27 4 1176 1189.e5 10.1016/j.celrep.2019.03.028 31018132
    [Google Scholar]
  198. Xu J. Tang Y. Sheng X. Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling. EMBO J. 2020 39 7 e103255 10.15252/embj.2019103255 32128839
    [Google Scholar]
  199. Bou Saleh M. Louvet A. Ntandja-Wandji L.C. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis. J. Hepatol. 2021 75 4 912 923 10.1016/j.jhep.2021.05.041 34129887
    [Google Scholar]
  200. Zhu C. Tabas I. Schwabe R.F. Pajvani U.B. Maladaptive regeneration — The reawakening of developmental pathways in NASH and fibrosis. Nat. Rev. Gastroenterol. Hepatol. 2021 18 2 131 142 10.1038/s41575‑020‑00365‑6 33051603
    [Google Scholar]
  201. LaCanna R. Liccardo D. Zhang P. Yap/Taz regulate alveolar regeneration and resolution of lung inflammation. J. Clin. Invest. 2019 129 5 2107 2122 10.1172/JCI125014 30985294
    [Google Scholar]
  202. Nowell C.S. Odermatt P.D. Azzolin L. Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction. Nat. Cell Biol. 2016 18 2 168 180 10.1038/ncb3290 26689676
    [Google Scholar]
  203. Yang M. Zhang Y. Fang C. Urine‐microenvironment‐initiated composite hydrogel patch reconfiguration propels scarless memory repair and reinvigoration of the urethra. Adv. Mater. 2022 34 14 2109522 10.1002/adma.202109522 35120266
    [Google Scholar]
  204. Namoto K. Baader C. Orsini V. NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo. Cell Stem Cell 2024 31 4 554 569.e17 10.1016/j.stem.2024.03.003 38579685
    [Google Scholar]
  205. Luo J.H. Wang F.X. Zhao J.W. PDIA3 defines a novel subset of adipose macrophages to exacerbate the development of obesity and metabolic disorders. Cell Metab. 2024 36 10 2262 2280.e5 10.1016/j.cmet.2024.08.009 39293433
    [Google Scholar]
  206. Li J. Razumilava N. Gores G.J. Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangio-cyte proliferation. J. Clin. Invest. 2014 124 7 3241 3251 10.1172/JCI73742 24892809
    [Google Scholar]
  207. Su T. Bondar T. Zhou X. Zhang C. He H. Medzhitov R. Two-signal requirement for growth-promoting function of Yap in hepatocytes. eLife 2015 4 e02948 10.7554/eLife.02948 25667983
    [Google Scholar]
  208. Kudo M. Melton A.C. Chen C. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat. Med. 2012 18 4 547 554 10.1038/nm.2684 22388091
    [Google Scholar]
  209. Huang Y. Clarke F. Karimi M. CRK proteins selectively regulate T cell migration into inflamed tissues. J. Clin. Invest. 2015 125 3 1019 1032 10.1172/JCI77278 25621495
    [Google Scholar]
  210. Sun H. Kamanova J. Lara-Tejero M. Galán J.E. Salmonella stimulates pro-inflammatory signalling through p21-activated kinases bypassing innate immune receptors. Nat. Microbiol. 2018 3 10 1122 1130 10.1038/s41564‑018‑0246‑z 30224799
    [Google Scholar]
  211. Kardash E Reichman-Fried M Maître JL A role for Rho GTPases and cell–cell adhesion in single-cell motility in vivo. Nat Cell Biol 2010 12 1 47-53, 1-11 10.1038/ncb2003 20010816
    [Google Scholar]
  212. Fayngerts S.A. Wang Z. Zamani A. Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein TIPE2. Nat. Immunol. 2017 18 12 1353 1360 10.1038/ni.3866 29058702
    [Google Scholar]
  213. Ward S.G. Do phosphoinositide 3-kinases direct lymphocyte navigation? Trends Immunol. 2004 25 2 67 74 10.1016/j.it.2003.12.003 15102365
    [Google Scholar]
  214. Chu J.Y. Dransfield I. Rossi A.G. Vermeren S. Non-canonical PI3K-Cdc42-Pak-Mek-Erk signaling promotes immune-complex-induced apoptosis in human neutrophils. Cell Rep. 2016 17 2 374 386 10.1016/j.celrep.2016.09.006 27705787
    [Google Scholar]
  215. Liu X. Yang T. Suzuki K. Moesin and myosin phosphatase confine neutrophil orientation in a chemotactic gradient. J. Exp. Med. 2015 212 2 267 280 10.1084/jem.20140508 25601651
    [Google Scholar]
  216. Aktories K. Schwan C. Jank T. Clostridium difficile Toxin Biology. Annu. Rev. Microbiol. 2017 71 1 281 307 10.1146/annurev‑micro‑090816‑093458 28657883
    [Google Scholar]
  217. Rozo C. Chinenov Y. Maharaj R.K. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE. Ann. Rheum. Dis. 2017 76 4 740 747 10.1136/annrheumdis‑2016‑209850 28283529
    [Google Scholar]
  218. Wegmann F. Petri B. Khandoga A.G. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J. Exp. Med. 2006 203 7 1671 1677 10.1084/jem.20060565 16818677
    [Google Scholar]
  219. Satchi-Fainaro R. Mamluk R. Wang L. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005 7 3 251 261 10.1016/j.ccr.2005.02.007 15766663
    [Google Scholar]
  220. Eelen G. Dubois C. Cantelmo A.R. Role of glutamine synthetase in angiogenesis beyond glutamine synthesis. Nature 2018 561 7721 63 69 10.1038/s41586‑018‑0466‑7 30158707
    [Google Scholar]
  221. Allen R.J. Porte J. Braybrooke R. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: A genome-wide association study. Lancet Respir. Med. 2017 5 11 869 880 10.1016/S2213‑2600(17)30387‑9 29066090
    [Google Scholar]
  222. Ahmad T. Mukherjee S. Pattnaik B. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J. 2014 33 9 994 1010 10.1002/embj.201386030 24431222 PMC4193933
    [Google Scholar]
  223. Vaughan L. Tan C.T. Chapman A. HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion. Cell Rep. 2015 10 1 88 102 10.1016/j.celrep.2014.12.012 25543140
    [Google Scholar]
  224. Crosas-Molist E. Samain R. Kohlhammer L. Rho GTPase signaling in cancer progression and dissemination. Physiol. Rev. 2022 102 1 455 510 10.1152/physrev.00045.2020 34541899
    [Google Scholar]
  225. Bokoch G.M. Regulation of innate immunity by Rho GTPases. Trends Cell Biol. 2005 15 3 163 171 10.1016/j.tcb.2005.01.002 15752980
    [Google Scholar]
  226. Liu W. Gao R. Yang C. ECM-mimetic immune-modulatory hydrogel for methicillin-resistant Staphylococcus aureus –infected chronic skin wound healing. Sci. Adv. 2022 8 27 eabn7006 10.1126/sciadv.abn7006 35857459
    [Google Scholar]
  227. Zhang Y. Zhang H. Zhao S. S-Nitrosylation of septin2 exacerbates aortic aneurysm and dissection by coupling the TIAM1-RAC1 axis in macrophages. Circulation 2024 149 24 1903 1920 10.1161/CIRCULATIONAHA.123.066404 38357802
    [Google Scholar]
  228. Meli V.S. Atcha H. Veerasubramanian P.K. YAP-mediated mechanotransduction tunes the macrophage inflammatory response. Sci. Adv. 2020 6 49 eabb8471 10.1126/sciadv.abb8471 33277245
    [Google Scholar]
  229. Cai H. Kondo M. Sandhow L. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression. Blood 2022 139 20 3040 3057 10.1182/blood.2021011510 34958665
    [Google Scholar]
  230. Jaillon S. Ponzetta A. Di Mitri D. Santoni A. Bonecchi R. Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer 2020 20 9 485 503 10.1038/s41568‑020‑0281‑y 32694624
    [Google Scholar]
  231. Liu A. Wang Q. Zhao Z. Nitric oxide nanomotor driving exosomes-loaded microneedles for achilles tendinopathy healing. ACS Nano 2021 15 8 13339 13350 10.1021/acsnano.1c03177 34324304
    [Google Scholar]
  232. Lin S. Wang J. Mukherjee P.K. Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis. Gut 2024 73 7 1110 1123 10.1136/gutjnl‑2022‑328608 38378253
    [Google Scholar]
  233. Miguel V. Shaw I.W. Kramann R. Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat. Rev. Nephrol. 2025 21 1 39 56 10.1038/s41581‑024‑00889‑z 39289568
    [Google Scholar]
  234. Huang J. Yang R. Jiao J. A click chemistry-mediated all-peptide cell printing hydrogel platform for diabetic wound healing. Nat. Commun. 2023 14 1 7856 10.1038/s41467‑023‑43364‑2 38030636
    [Google Scholar]
  235. Han F. Tu Z. Zhu Z. Targeting endogenous reactive oxygen species removal and regulating regenerative microenvironment at annulus fibrosus defects promote tissue repair. ACS Nano 2023 17 8 7645 7661 10.1021/acsnano.3c00093 37022700
    [Google Scholar]
  236. Shen Y. Wang X. Lu J. Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer. Cancer Cell 2020 37 6 800 817.e7 10.1016/j.ccell.2020.05.005 32516590
    [Google Scholar]
  237. Sharifi M.A. Wierer M. Dang T.A. ADAMTS-7 modulates atherosclerotic plaque formation by degradation of TIMP-1. Circ. Res. 2023 133 8 674 686 10.1161/CIRCRESAHA.123.322737 37675562
    [Google Scholar]
  238. Liang G. Wang S. Shao J. Tenascin-X mediates flow-induced suppression of EndMT and atherosclerosis. Circ. Res. 2022 130 11 1647 1659 10.1161/CIRCRESAHA.121.320694 35443807
    [Google Scholar]
  239. Cai X. Han M. Lou F. Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. Nat. Commun. 2023 14 1 2004 10.1038/s41467‑023‑37798‑x 37037861
    [Google Scholar]
  240. Zhao G. Gentile M.E. Xue L. Vascular endothelial-derived SPARCL1 exacerbates viral pneumonia through pro-inflammatory macrophage activation. Nat. Commun. 2024 15 1 4235 10.1038/s41467‑024‑48589‑3 38762489
    [Google Scholar]
  241. Spang M.T. Middleton R. Diaz M. Intravascularly infused extracellular matrix as a biomaterial for targeting and treating inflamed tissues. Nat. Biomed. Eng. 2022 7 2 94 109 10.1038/s41551‑022‑00964‑5 36581694
    [Google Scholar]
  242. Meng Q. Xie E. Sun H. High‐strength smart microneedles with “offensive and defensive” effects for intervertebral disc repair. Adv. Mater. 2024 36 2 2305468 10.1002/adma.202305468 37681640
    [Google Scholar]
  243. Song W. Guo Y. Liu W. Circadian rhythm‐regulated ADSC‐derived sEVs and a triphasic microneedle delivery system to enhance tendon‐to‐bone healing. Adv. Mater. 2024 36 39 2408255 10.1002/adma.202408255 39120049
    [Google Scholar]
  244. Chang M. Nguyen T.T. Strategy for treatment of infected diabetic foot ulcers. Acc. Chem. Res. 2021 54 5 1080 1093 10.1021/acs.accounts.0c00864 33596041
    [Google Scholar]
  245. Guan T. Li J. Chen C. Liu Y. Self‐assembling peptide‐based hydrogels for wound tissue repair. Adv. Sci. (Weinh.) 2022 9 10 2104165 10.1002/advs.202104165 35142093
    [Google Scholar]
  246. Hendrikx T. Porsch F. Kiss M.G. Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. J. Hepatol. 2022 77 5 1373 1385 10.1016/j.jhep.2022.06.004 35750138
    [Google Scholar]
  247. Monticelli S. Sommer A. AlHajj Hassan Z. Early-wave macrophages control late hematopoiesis. Dev. Cell 2024 59 10 1284 1301.e8 10.1016/j.devcel.2024.03.013 38569551
    [Google Scholar]
/content/journals/cmm/10.2174/0115665240407854251202120058
Loading
Dynamic Changes of Extracellular Matrix in Sepsis: A Review
Bentham Science Publishers ; https://doi.org/10.2174/0115665240407854251202120058
/content/journals/cmm/10.2174/0115665240407854251202120058
/content/journals/cmm/10.2174/0115665240407854251202120058
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: CD44 ; proteoglycans ; elastin ; Integrins ; collagens ; DDRs

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test